Online Advance Care Planning Tool for Cognitive Impairment
(Portal-Voice Trial)
Trial Summary
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment ACPVoice, ACP Portal-Based Tool, ACPVoice for cognitive impairment?
Is the ACPVoice tool safe for use in humans?
How is the ACPVoice treatment different from other treatments for cognitive impairment?
ACPVoice is unique because it is an online tool specifically designed to help people with cognitive impairment engage in advance care planning (ACP) by using a patient portal. It focuses on improving understanding and communication about future medical decisions, which is different from traditional treatments that may not address these specific needs.237910
What is the purpose of this trial?
The purpose of this research is to examine the feasibility of using a patient portal based advance care planning (ACP) tool to improve ACP discussions and documentation in persons living with cognitive impairment in outpatient primary care.
Research Team
Jennifer Gabbard, MD
Principal Investigator
Wake Forest University Health Sciences
Eligibility Criteria
This trial is for community-dwelling adults with cognitive impairment who are under outpatient primary care. The study aims to include those who may benefit from improved discussions and documentation of their future healthcare preferences.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Intervention Implementation
Participants receive the ACPVoice tool via the patient portal, paired with a motivational message, to improve advance care planning discussions and documentation.
Follow-up
Participants are monitored for the effectiveness of the ACPVoice tool in improving advance care planning documentation and discussions.
Treatment Details
Interventions
- ACPVoice
Find a Clinic Near You
Who Is Running the Clinical Trial?
Wake Forest University Health Sciences
Lead Sponsor
National Institute on Aging (NIA)
Collaborator